Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Xu, Fengyan ^a   Zhou, Guiqin ^a   Han, Shaoli ^a   Yuan, Weiguang ^a   Chen, Shuang ^a   Fu, Zhenkun ^a   Li, Dalin ^a   Zhang, Hua ^a   Li, Dianjun ^a   Pang, Da ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; ESTROGEN RECEPTOR; GUANINE; PROGESTERONE RECEPTOR; PROTEIN P53; THYMINE; TUMOR NECROSIS FACTOR ALPHA; TNFRSF1A PROTEIN, HUMAN; TNFRSF1B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TNF ALPHA GENE; TNFRSF1A GENE; TNFRSF1B GENE; TUMOR GENE; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; ETHNIC GROUP; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904265535     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101138     Document Type: Article

References (41)

1. Ben-Baruch A (2003) Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 5: 31-36.
2. Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4: 221-233.
3. Lejeune FJ, Ruegg C, Lienard D (1998) Clinical applications of TNF-alpha in cancer. Curr Opin Immunol 10: 573-580.
4. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545. (Pubitemid 32173595)
5. Balkwill F (2002) Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Res 13: 135-141.
6. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G (2006) Inflammation and cancer: how hot is the link? Biochem Pharmacol 72: 1605-1621. (Pubitemid 44666739)
7. Leek RD, Landers R, Fox SB, Ng F, Harris AL, et al. (1998) Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Brit J Cancer 77: 2246-2251. (Pubitemid 28263948)
8. Ferrajoli A, Keating MJ, Manshouri T, Giles FJ, Dey A, et al. (2002) The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia. Blood 100: 1215-1219. (Pubitemid 34864274)
9. Garcia-Tunon I, Ricote M, Ruiz A, Fraile B, Paniagua R, et al. (2006) Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and infiltrative). Cancer Sci 97: 1044-1049. (Pubitemid 44322552)
10. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, et al. (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466. (Pubitemid 39329586)
11. Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, Beguelin W, et al. (2008)TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways. Exp cell Res 314: 509-529.
12. Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, et al. (1994) Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue. Int J Cancer 56: 777-782. (Pubitemid 24102739)
13. Tran TA, Kallakury BV, Ambros RA, Ross JS (1998) Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma. Cancer 83: 276-282. (Pubitemid 28317807)
14. Park KS, Mok JW, Ko HE, Tokunaga K, Lee MH (2002) Polymorphisms of tumour necrosis factors A and B in breast cancer. Eur J Immunogene 29: 7-10. (Pubitemid 34146653)
15. Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, et al. (2004) Role of tumour necrosis factor gene polymorphisms (2308 and 2238) in breast cancer susceptibility and severity. Breast Cancer Res 6: R395-400.
16. Kamali-Sarvestani E, Merat A, Talei AR (2005) Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer. Cancer Lett 223: 113-119. (Pubitemid 40693715)
17. Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, et al. (2007) Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 121: 483-490. (Pubitemid 46554685)
18. Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, et al. (2009) Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population. Breast Cancer Res Treat 114: 347-355.
19. Pooja S, Francis A, Bid HK, Kumar S, Rajender S, et al. (2011) Role of ethnic variations in TNF-alpha and TNF-beta polymorphisms and risk of breast cancer in India. Breast Cancer Res Treat 126: 739-747.
20. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, et al. (2009) Metaanalysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat genet 41: 776-782.
21. Davidson SI, Liu Y, Danoy PA, Wu X, Thomas GP, et al. (2011) Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis 70: 289-292.
22. International Multiple Sclerosis Genetics C(2011) The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter casecontrol study. PloS One 6: e18813.
23. Karaderi T, Pointon JJ, Wordsworth TW, Harvey D, Appleton LH, et al. (2012) Evidence of genetic association between TNFRSF1A encoding the p55 tumour necrosis factor receptor, and ankylosing spondylitis in UK Caucasians. Clin Exp Rheumatol 30: 110-113.
24. Xu F, Li D, Zhang Q, Fu Z, Yuan W, et al. (2012) Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province. Breast Cancer Res Treat 133(3): 1105-13.
25. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, et al. (1997) TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 72: 149-153. (Pubitemid 27062770)
26. Kroeger KM, Carville KS, Abraham LJ (1997) The -308 tumor necrosis factoralpha promoter polymorphism effects transcription. Mol Immunol 34: 391-399. (Pubitemid 27368335)
27. Fang F, Yao L, Yu XJ, Yu L, Wu Q, et al. (2010) TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls. Breast Cancer Res Treat 122: 267-271.
28. Yang Y, Feng R, Bi S, Xu Y (2011) TNF-alpha polymorphisms and breast cancer. Breast Cancer Res Treat 129: 513-519.
29. Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C (2009) Silent (synonymous) SNPs: should we care about them? Methods Mol Biol 578: 23-39.
30. Madeleine MM, Johnson LG, Malkki M, Resler AJ, Petersdorf EW, et al. (2011) Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer. Breast Cancer Res Treat 129: 887-899.
31. Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, et al. (1999) Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18: 3034-3043. (Pubitemid 29255612)
32. Till A, Rosenstiel P, Krippner-Heidenreich A, Mascheretti-Croucher S, Croucher PJ, et al. (2005) The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression. J Biol Chem 280: 5994-6004. (Pubitemid 40280083)
33. Guan X, Liao Z, Ma H, Qian J, Liu Z, et al. (2011) TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy. BMC cancer 11: 447.
34. Steenholdt C, Enevold C, Ainsworth MA, Brynskov J, Thomsen OO, et al. (2012) Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease. Aliment pharmacol Ther 36: 650-659.
35. Ni B, Chen S, Xie H, Ma H (2014) Functional polymorphisms in interleukin-23 receptor and susceptibility to esophageal squamous cell carcinoma in chinese population. PLoS One 2014 28; 9(2): e89111.
36. Ferguson LR, Han DY, Huebner C, Petermann I, Barclay ML, et al. (2009) Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand caucasian population. Gastroenterol Res Pract 591704.
37. Mokrousov I, Wu XR, Vyazovaya A, Feng WX, Sun L, et al. (2011) Polymorphism of 3′UTR region of TNFR2 coding gene and its role in clinical tuberculosis in Han Chinese pediatric population. Infect Genet Evol 11: 1312-1318.
38. Stendahl M, Ryden L, Nordenskjold B, Jonsson PE, Landberg G, et al. (2006) High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients. Clin Cancer Res 12: 4614-4618. (Pubitemid 44297812)
39. Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, et al. (2007) Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol 25: 4772-4778. (Pubitemid 350086480)
40. Weiss RB, Woolf SH, Demakos E, Holland JF, Berry DA, et al. (2003) Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. J Clin Oncol 21 (9): 1825-1835. (Pubitemid 46638596)
41. Muller PA, Vousden KH, Norman JC (2011) p53 and its mutants in tumor cell migration and invasion. J Cell Biol 192(2): 209-218.